The "Start-Stop" Reality: New Data Reveals Complex Patterns in GLP-1 Adherence for Type 2 Diabetes
Comments Off on The "Start-Stop" Reality: New Data Reveals Complex Patterns in GLP-1 Adherence for Type 2 Diabetes
June 17, 2026
CHICAGO — The landscape of type 2 diabetes management has been irrevocably altered by the rise of glucagon-like peptide-1 (GLP-1) receptor agonists. Drugs like liraglutide, semaglutide, and tirzepatide have become cornerstones of modern metabolic…
